Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
15846 | 620 | 39.4 | 83% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | F 18 FLT | Author keyword | 49 | 69% | 7% | 42 |
2 | F 18FLT | Author keyword | 49 | 82% | 5% | 28 |
3 | FLT | Author keyword | 32 | 47% | 8% | 50 |
4 | FLUOROTHYMIDINE | Author keyword | 32 | 78% | 3% | 21 |
5 | 3 DEOXY 3 F 18 FLUOROTHYMIDINE | Author keyword | 23 | 100% | 2% | 10 |
6 | F 18 FLUOROTHYMIDINE | Author keyword | 21 | 73% | 3% | 16 |
7 | F 18FLUOROTHYMIDINE | Author keyword | 12 | 86% | 1% | 6 |
8 | FLT PET | Author keyword | 10 | 50% | 2% | 14 |
9 | 3 DEOXY 3 FLUOROTHYMIDINE | Author keyword | 9 | 83% | 1% | 5 |
10 | MOL THER Y PET ONCOL GRP | Address | 9 | 83% | 1% | 5 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | F 18 FLT | 49 | 69% | 7% | 42 | Search F+18+FLT | Search F+18+FLT |
2 | F 18FLT | 49 | 82% | 5% | 28 | Search F+18FLT | Search F+18FLT |
3 | FLT | 32 | 47% | 8% | 50 | Search FLT | Search FLT |
4 | FLUOROTHYMIDINE | 32 | 78% | 3% | 21 | Search FLUOROTHYMIDINE | Search FLUOROTHYMIDINE |
5 | 3 DEOXY 3 F 18 FLUOROTHYMIDINE | 23 | 100% | 2% | 10 | Search 3++DEOXY+3++F+18+FLUOROTHYMIDINE | Search 3++DEOXY+3++F+18+FLUOROTHYMIDINE |
6 | F 18 FLUOROTHYMIDINE | 21 | 73% | 3% | 16 | Search F+18+FLUOROTHYMIDINE | Search F+18+FLUOROTHYMIDINE |
7 | F 18FLUOROTHYMIDINE | 12 | 86% | 1% | 6 | Search F+18FLUOROTHYMIDINE | Search F+18FLUOROTHYMIDINE |
8 | FLT PET | 10 | 50% | 2% | 14 | Search FLT+PET | Search FLT+PET |
9 | 3 DEOXY 3 FLUOROTHYMIDINE | 9 | 83% | 1% | 5 | Search 3++DEOXY+3++FLUOROTHYMIDINE | Search 3++DEOXY+3++FLUOROTHYMIDINE |
10 | FBAU | 8 | 75% | 1% | 6 | Search FBAU | Search FBAU |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | IMAGING PROLIFERATION | 138 | 72% | 18% | 109 |
2 | F 18 FLT PET | 102 | 89% | 8% | 47 |
3 | KI 67 IMMUNOHISTOCHEMISTRY | 61 | 95% | 3% | 20 |
4 | PROLIFERATION IN VIVO | 43 | 57% | 8% | 50 |
5 | 3 DEOXY 3 F 18 FLUOROTHYMIDINE | 38 | 93% | 2% | 14 |
6 | C 11 LABELED THYMIDINE | 34 | 93% | 2% | 13 |
7 | F 18 FLT | 29 | 71% | 4% | 24 |
8 | LABELED THYMIDINE | 27 | 83% | 2% | 15 |
9 | FLT PET | 24 | 91% | 2% | 10 |
10 | 3 DEOXY 3 FLUOROTHYMIDINE | 19 | 68% | 3% | 17 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Imaging of cell proliferation: Status and prospects | 2008 | 137 | 119 | 68% |
Correlation between Ki-67 immunohistochemistry and 18F-Fluorothymidine uptake in patients with cancer: A systematic review and meta-analysis | 2012 | 39 | 62 | 55% |
Molecular PET and PET/CT imaging of tumour cell proliferation using F-18 fluoro-L-thymidine: a comprehensive evaluation | 2009 | 48 | 77 | 94% |
[F-18]FLT-PET in oncology: current status and opportunities | 2004 | 134 | 64 | 48% |
PET/CT Imaging in Cancer: Current Applications and Future Directions | 2014 | 5 | 122 | 20% |
In vivo measurement of cell proliferation in canine brain tumor using C-11-labeled FMAU and PET | 2008 | 13 | 34 | 71% |
Building PET research collaborations | 2012 | 0 | 4 | 100% |
Nucleoside-based probes for imaging tumor proliferation using positron emission tomography | 2013 | 2 | 68 | 59% |
Applications of PET imaging with the proliferation marker [F-18]-FLT | 2015 | 0 | 34 | 88% |
Feasibility studies of 4 '-[methyl-C-11]thiothymidine as a tumor proliferation imaging agent in mice | 2008 | 11 | 26 | 62% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MOL THER Y PET ONCOL GRP | 9 | 83% | 0.8% | 5 |
2 | IRSL CYCLOTRON UNIT | 3 | 100% | 0.5% | 3 |
3 | COMPREHENS CANC IMAGING | 3 | 20% | 2.1% | 13 |
4 | MOL IMAGING TRANSLAT PROGRAM | 2 | 38% | 0.8% | 5 |
5 | PROGRAM CHEM PHYS BIOL | 2 | 17% | 1.5% | 9 |
6 | PET NETWORK PRN | 1 | 100% | 0.3% | 2 |
7 | PROBE SECT | 1 | 50% | 0.3% | 2 |
8 | SEKT RADIOPHARM | 1 | 100% | 0.3% | 2 |
9 | LUNG CLIN MERHEIM | 1 | 40% | 0.3% | 2 |
10 | LDM TEP GRP | 1 | 33% | 0.3% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000259060 | C 11 METHIONINE//O 2 F 18FLUOROETHYL L TYROSINE//FET PET |
2 | 0.0000192960 | HSV1 TK//FIAU//RADIOCHEM CYCLOTRON CORE IL |
3 | 0.0000161216 | SUV//STANDARDIZED UPTAKE VALUE//LUNG NEOPLASMS EMISSION CT ECT |
4 | 0.0000141016 | C 11 CHOLINE PET CT//C 11 CHOLINE//CHOLINE PET |
5 | 0.0000138768 | THYMIDINE KINASE 1//SERUM THYMIDINE KINASE 1//DNA SYNTHESIZING ENZYMES |
6 | 0.0000120877 | B2T//BREAST DIS UNIT//POSITRON EMISSION MAMMOGRAPHY |
7 | 0.0000105148 | IMAGE DERIVED INPUT FUNCTION//INPUT FUNCTION//BIOMED MULTIMEDIA INFORMAT TECHNOL GRP |
8 | 0.0000095515 | TC 99M ANNEXIN V//ANNEXIN V//APOPTOSIS IMAGING |
9 | 0.0000095398 | FLUOROESTRADIOL//F 18 FES PET//FES PET |
10 | 0.0000095133 | PLANNED NECK DISSECTION//NECK MANAGEMENT//NECK DISSECTION |